Zepp Health Corp (NYSE:ZEPP)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Loses money on what it sells.
- Revenue
- $1.93B
- Net income
- -$301.5M
- Net margin
- -15.6%
Heavily indebted for what it earns.
- Total debt
- $1.67B
- Cash
- $721.4M
- Debt / equity
- 1.33
Owes more within a year than it holds to pay it.
- Current assets
- $1.92B
- Current liabilities
- $2.13B
- Current ratio
- 0.90
Consumes cash and must keep raising it.
- Operating cash flow
- -$179.7M
- Free cash flow
- -$185.1M
- FCF margin
- -9.6%
Not funding itself by issuing shares.
- Shares outstanding
- 1.0M
- Share growth (1y)
- -93.8%
- Cash runway
- 48 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
ZEPP Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 433.59 M | 355.82 M | 598.12 M | 539.56 M | 427.07 M | 279.89 M |
| Revenue Growth (YoY) | 1.53 % | 27.13 % | 38.13 % | 81.26 % | 44.61 % | -3.12 % |
| Cost of Revenue | 268.26 M | 218.27 M | 353.03 M | 333.65 M | 272.57 M | 175.59 M |
| Gross Profit | 165.33 M | 137.55 M | 245.09 M | 205.91 M | 154.50 M | 104.30 M |
| SG&A Expense | 167.14 M | 165.64 M | 191.76 M | 135.30 M | 118.15 M | 147.86 M |
| R&D Expense | 78.80 M | 0.00 | 77.13 M | 76.90 M | 80.21 M | 89.89 M |
| Operating Expenses | 249.32 M | 259.68 M | 272.28 M | 212.20 M | 198.35 M | 237.76 M |
| Operating Income | -83.99 M | -122.13 M | -27.19 M | -6.29 M | -43.85 M | -133.45 M |
| Pretax Income | -76.56 M | -134.12 M | -62.53 M | -10.67 M | -53.90 M | -142.58 M |
| Tax Provision | 778.11 K | 1.48 M | 14.52 M | 832.96 K | 1.74 M | 798.91 K |
| Net Income | -77.33 M | -135.59 M | -77.05 M | -11.50 M | -55.64 M | -143.37 M |
| EPS (Basic) | -78.56 | -136.48 | -77.12 | -0.71 | -3.52 | -9.28 |
| EPS (Diluted) | -78.56 | -136.48 | -77.12 | -0.71 | -3.52 | -8.96 |
| Shares Outstanding | 989.67 K | 991.91 K | 992.32 K | 15.82 M | 15.85 M | 15.42 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.